CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art Review Infective Endocarditis After Transcatheter Aortic Valve Replacement Dual Antiplatelet TherapyIs It Time to Cut the Cord With Aspirin? Impact of Percutaneous Revascularization on Exercise Hemodynamics in Patients With Stable Coronary Disease New-onset atrial fibrillation after PCI and CABG for left main disease: insights from the EXCEL trial and additional studies

Clinical Trial2020 Nov 5;S0002-8703(20)30368-9.

JOURNAL:Am Heart J. Article Link

Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial

H Kawashima, O Soliman, PW Serruys et al. Keywords: aortic stenosis; balloon-expandable valve; paravalvular regurgitation; permanent pacemaker implantation; randomized trial; TAVR; transcatheter heart valve

Full Text PDF